Chinese regulators focus on homegrown COVID-19 therapies to tackle new variants: GlobalData EP News Bureau Feb 21, 2023 There are currently 16 COVID-19 drugs in clinical development in China, five of which are in Phase III. Most of these drugs in the…
Covid vaccines do not increase risk of adverse events: Study PTI Feb 11, 2023 The study is currently the only one in the world that monitored the population for more than a year, taking into account numerous…
Scientists develop molecule that blocks COVID-19 infection Press Trust of India Dec 16, 2021 The researchers at Aarhus University in Denmark noted that the molecule is cheaper and easier to manufacture than the antibodies…
